Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novo Nordisk A/S
NOVACurrent price
121.5 EUR
+4.5 EUR (+3.85%)
Last closed
129.78 USD
Company
www.novonordisk.com
ISIN
US6701002056
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
576 212 828 160 USD
Yield for 12 month
+37.46 %
1Y
3Y
5Y
10Y
15Y
NOVA
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Alle 1, Bagsvaerd, Denmark, 2880
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
148.23 USDP/E ratio
43.5503Dividend Yield
1.11 %Current Year
+34 286 641 347 USD
Last Year
+26 122 157 111 USD
Current Quarter
+10 047 097 059 USD
Last Quarter
+9 646 896 058 USD
Current Year
+29 006 970 081 USD
Last Year
+21 922 629 972 USD
Current Quarter
+8 530 437 124 USD
Last Quarter
+8 183 084 503 USD
Key Figures NOVA
1 year
3 years
5 years
10 years
EBITDA
126 561 001 472 USD
Operating Margin TTM
PE Ratio
43.5503
Return On Assets TTM
22.8 %
PEG Ratio
1.9632
Return On Equity TTM
88.57 %
Wall Street Target Price
148.23 USD
Revenue TTM
258 002 993 152 USD
Book Value
25.24 USD
Revenue Per Share TTM
Dividend Share
9.9 USD
Quarterly Revenue Growth YOY
25.3 %
Dividend Yield
1.11 %
Gross Profit TTM
148 506 000 000 USD
Earnings per share
2.98 USD
Diluted Eps TTM
2.98 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
3.9 %
Profit Margin
34.84 %
Dividend Analytics NOVA
Dividend growth over 5 years
62 %Continuous growth
5 yearsPayout Ratio 5 years average
19 %Dividend History NOVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.45
Ex Dividend Date
16.08.2024
Forward Annual Dividend Yield
1.11 %
Last Split Factor
2:1
Payout Ratio
35.01 %
Last Split Date
20.09.2023
Dividend Date
26.08.2024
Stock Valuation NOVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
43.5503
Forward PE
31.9489
Enterprise Value Revenue
15.081
Price Sales TTM
2.2334
Enterprise Value EBITDA
29.0559
Price Book MRQ
34.5575
Financials NOVA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NOVA
For 52 weeks
86.19 USD
147.59 USD
50 Day MA
134.46 USD
Shares Short Prior Month
3 150 922
200 Day MA
124.74 USD
Short Ratio
1.07
Shares Short
5 270 451
Short Percent
0.17 %
BeatStart